CDNA CareDx, Inc. - Common Stock
NASDAQ · Biotechnology · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Lip 30, 2026
$67,15
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$13,9552tyg. minimum
$69,8052tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$3.46B
P/E (TTM)
32.4
EPS (TTM)
$2.07
Przychody (TTM)
$458M
Twoje odznaki
Zakres 52 tyg.
$14–$70
Ocena Analityków
STRONG BUY
Cena Docelowa
$59
P/E
32.4
ROE
29.5%
Marża Zysku Netto
24.2%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
CDNA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$67.15
Kapitalizacja Rynkowa (MRQ)
$3.46B
P/E (TTM)
32.4
EPS (TTM)
$2.07
Przychody (TTM)
$458M
ROE (TTM)
29.5%
Zakres 52 tyg.
$14–$70
CDNA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
O CareDx, Inc. - Common Stock Przegląd firmy z Wikipedii
sektorHealthcare
branżaBiotechnology
pracownicy761
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$380M2017-12-31 → 2025-12-31
EPS$-0.402017-12-31 → 2025-12-31
Wolny przepływ pieniężny·2017-12-31 → 2018-12-31
Marża netto24.2%2017-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | CDNA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 32.4średnia z 5 lat ≈-22.5 | ≈-22.5 | 27.9 | Niedowartościowany | |
| P/S (TTM) | 7.5średnia z 5 lat ≈3.7 | ≈3.7 | 11.9 | Niedowartościowany | |
| P/B (MRQ) | 8.1średnia z 5 lat ≈3.0 | ≈3.0 | 4.2 | Niedowartościowany | |
| Price / Cash Flow (Cena / Przepływy pieniężne) | 81.9średnia z 5 lat ≈-25.8 | ≈-25.8 | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | 8.5średnia z 5 lat ≈3.9 | ≈3.9 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | CDNA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | 23.6%średnia z 5 lat ≈-20.5% | ≈-20.5% | 12.5% | Najwyższa półka | |
| Marża EBITDA (TTM) | 26.8%średnia z 5 lat ≈-17.8% | ≈-17.8% | 12.5% | Najwyższa półka | |
| Marża przed opodatkowaniem (TTM) | 25.1%średnia z 5 lat ≈-18.4% | ≈-18.4% | 16.4% | Najwyższa półka | |
| Marża Zysku Netto (TTM) | 24.2%średnia z 5 lat ≈-18.4% | ≈-18.4% | 10.2% | Najwyższa półka | |
| ROA (TTM) | 22.7%średnia z 5 lat ≈-10.4% | ≈-10.4% | -13.8% | Najwyższa półka | |
| ROE (TTM) | 29.5%średnia z 5 lat ≈-14.5% | ≈-14.5% | -10.7% | Najwyższa półka | |
| ROIC | -10.3%średnia z 5 lat ≈-20.3% | ≈-20.3% | -12.3% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | CDNA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 4.6średnia z 5 lat ≈4.3 | ≈4.3 | 4.6 | Zgodnie z | |
| Wskaźnik Szybkości (MRQ) | 4.4średnia z 5 lat ≈4.0 | ≈4.0 | 4.1 | Zgodnie z |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | CDNA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 13.8%średnia z 5 lat ≈16.6% | ≈16.6% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 5.7%średnia z 5 lat ≈7.7% | ≈7.7% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 14.6% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | CDNA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.8średnia z 5 lat ≈0.7 | ≈0.7 | 0.4 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 7.1średnia z 5 lat ≈5.8 | ≈5.8 | 8.4 | Poniżej średniej | |
| Revenue / Employee (Przychody / pracownika) | ≈$499.1K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
44.4%
Następny raport
Lis 02, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 4, 2026 | $0.37 | $0.24 | 55.8% |
| 31 marca 2026 | $0.34 | $0.14 | 149.6% | |
| 31 grudnia 2025 | $0.12 | $0.24 | -50.8% | |
| 30 września 2025 | $0.28 | $0.14 | 93.8% | |
| 30 czerwca 2025 | $0.10 | $0.12 | -18.1% | |
| 31 marca 2025 | $0.09 | $0.07 | 36.0% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $380M | $334M | $280M | $322M | $296M | $192M | $127M | $77M | $48M | $41M | $28M | $27M | |
| Cost of Revenue | · | · | · | · | · | · | $45M | $33M | $21M | $10M | $0 | $0 | |
| Gross Profit | · | · | · | · | · | · | $82M | $44M | $27M | · | · | · | |
| R&D Expense | $71M | $73M | $82M | $90M | $77M | $49M | $31M | $15M | $12M | $12M | $9M | $4M | |
| SG&A Expense | $108M | $125M | $119M | $100M | $75M | $49M | $37M | $23M | $20M | $21M | $12M | $8M | |
| Operating Expenses | $411M | $293M | $484M | $399M | $326M | $215M | $152M | $92M | $47M | $78M | $40M | $26M | |
| Operating Income | $-31M | $41M | $-203M | $-77M | $-30M | $-23M | $-25M | $-16M | $-20M | $-37M | $-12M | $1M | |
| Other Non-op | $524.0K | $329.0K | $1M | $-3M | $-3M | $-811.0K | $-719.0K | $-178.0K | $-1M | $-2M | $-188.0K | $-78.0K | |
| Pretax Income | $-21M | $53M | $-190M | $-76M | $-32M | $-20M | $-24M | $-48M | $-57M | $-41M | $-14M | $-719.0K | |
| Income Tax | $271.0K | $310.0K | $141.0K | $379.0K | $-1M | $-1M | $-2M | $-1M | $-2M | $-2M | $0 | $-2M | |
| Net Income | $-21M | $53M | $-190M | $-77M | $-31M | $-19M | $-22M | $-47M | $-55M | $-39M | $-14M | $781.0K | |
| EPS (Basic) | $-0.40 | $1.00 | $-3.54 | $-1.44 | $-0.59 | $-0.40 | $-0.52 | $-1.31 | $-2.38 | $-2.39 | $-1.16 | $0.13 | |
| EPS (Diluted) | $-0.40 | $0.93 | $-3.54 | $-1.44 | $-0.59 | $-0.40 | $-0.52 | $-1.31 | $-2.38 | $-2.39 | $-1.16 | $0.10 | |
| Shares (Basic) | 53,287,546 | 52,773,247 | 53,764,705 | 53,321,625 | 52,241,076 | 46,481,772 | 42,151,617 | 35,638,956 | 23,332,503 | 16,496,911 | 11,860,885 | 5,815,928 | |
| Shares (Diluted) | 53,287,546 | 56,620,590 | 53,764,705 | 53,321,625 | 52,241,076 | 46,481,772 | 42,151,617 | 35,638,956 | 23,332,503 | 16,496,911 | 11,860,885 | 9,283,001 | |
| EBITDA | $-16M | $55M | $-189M | $-77M | $-30M | $-23M | $-25M | $-16M | $-20M | · | · | $2M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $115M | $82M | $90M | $348M | $135M | $38M | $65M | $17M | $17M | $30M | $36M | |
| Short-term Investments | $112M | $146M | $153M | $203M | $0 | $90M | $0 | · | · | · | · | · | |
| Receivables | $43M | $65M | $51M | $66M | $60M | $35M | $24M | $10M | $3M | $3M | · | · | |
| Inventory | $27M | $20M | $19M | $19M | $17M | $10M | $6M | $5M | $6M | $5M | $766.0K | $686.0K | |
| Prepaid Expense | $11M | $7M | $8M | $9M | $8M | $4M | $4M | $2M | $1M | $1M | $1M | $542.0K | |
| Current Assets | $257M | $352M | $314M | $388M | $433M | $273M | $72M | $81M | $27M | $27M | $34M | $40M | |
| PP&E (Net) | $33M | $34M | $35M | $36M | $22M | $11M | $4M | $4M | $2M | $3M | $2M | $2M | |
| PP&E (Gross) | · | · | · | · | · | · | · | $18M | $18M | $17M | $14M | $13M | |
| Accum. Depreciation | · | · | · | · | · | · | · | $14M | $15M | $14M | $12M | $11M | |
| Goodwill | $40M | $40M | $40M | $38M | $37M | $24M | $24M | $12M | $12M | $14M | $12M | $12M | |
| Intangibles | $32M | $38M | $46M | $43M | $50M | $44M | $46M | $33M | $33M | $33M | $7M | $7M | |
| Other Non-current Assets | $3M | $2M | $1M | $4M | $6M | $1M | $1M | $0 | $0 | $20.0K | $49.0K | $25.0K | |
| Total Assets | $413M | $491M | $467M | $543M | $567M | $369M | $152M | $131M | $84M | $77M | $56M | $61M | |
| Accounts Payable | $10M | $8M | $13M | $10M | $13M | $10M | $6M | $5M | $3M | $3M | $2M | $1M | |
| Current Liabilities | $90M | $89M | $78M | $76M | $77M | $69M | $35M | $20M | $43M | $41M | $10M | $11M | |
| Capital Leases | $20M | $22M | $28M | $33M | $17M | $16M | $2M | $249.0K | $14.0K | $26.0K | $57.0K | $106.0K | |
| Deferred Tax | $181.0K | $164.0K | $136.0K | $0 | $415.0K | $1M | $2M | $3M | $5M | $6M | $0 | · | |
| Other Non-current Liabilities | $418.0K | $645.0K | $97M | $249.0K | $455.0K | $240.0K | $2M | $2M | $1M | $1M | $28.0K | $28.0K | |
| Total Liabilities | $110M | $113M | $205M | $112M | $101M | $91M | $53M | $35M | $90M | $57M | $26M | $20M | |
| Long-term Debt | · | · | · | · | · | $0 | $0 | $0 | $34M | $24M | $16M | $11M | |
| Total Debt | · | · | · | · | · | $0 | $0 | $0 | $34M | · | · | $11M | |
| Common Stock | $50.0K | $51.0K | $49.0K | $52.0K | $52.0K | $49.0K | $42.0K | $41.0K | $29.0K | $21.0K | $12.0K | $12.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | $236M | $203M | $201M | |
| Retained Earnings | $-619M | $-626M | $-678M | $-460M | $-383M | $-353M | $-334M | $-312M | $-268M | $-213M | $-173M | $-159M | |
| AOCI | $-6M | $-9M | $-7M | $-8M | $-5M | $-2M | $-5M | $-4M | $-2M | $-4M | $0 | · | |
| Stockholders' Equity | $303M | $378M | $261M | $431M | $466M | $278M | $99M | $96M | $-6M | $19M | $29M | $41M | |
| Liabilities + Equity | $413M | $491M | $467M | $543M | $567M | $369M | $152M | $131M | $84M | $77M | $56M | $61M | |
| Shares Outstanding | 50,916,644 | 54,771,203 | 51,503,377 | 53,533,250 | 52,923,360 | 49,441,166 | 42,498,430 | 41,384,960 | 28,825,019 | 21,278,373 | 11,902,363 | 11,803,970 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $14M | $14M | $12M | $9M | $7M | $6M | $4M | $4M | $3M | $796.0K | $512.0K | |
| Stock-based Comp | $35M | $66M | $49M | $47M | $36M | $23M | $22M | $7M | $2M | $2M | $1M | $535.0K | |
| Deferred Tax | $-149.0K | $101.0K | $72.0K | $-278.0K | $-1M | $-1M | $-1M | $-2M | $-2M | $-2M | $0 | $-2M | |
| Amort. of Intangibles | $6M | $6M | $6M | $6M | $6M | $5M | $4M | $2M | $3M | $2M | $0 | · | |
| Restructuring | · | $2M | $2M | $0 | $0 | · | · | · | · | · | · | · | |
| Other Non-cash | $14M | $-95M | $108M | · | · | · | · | · | · | · | · | $-5M | |
| Operating Cash Flow | $42M | $38M | $-18M | $-25M | $-19M | $33M | $-3M | $-4M | $-14M | $-17M | $-10M | $-3M | |
| CapEx | · | · | · | · | · | · | · | $2M | $186.0K | $549.0K | $1M | $733.0K | |
| Investing Cash Flow | $2M | $-483.0K | $40M | $-229M | $48M | $-100M | $-23M | $-8M | $-6M | $-21M | · | · | |
| Stock Issued | · | · | $0 | $0 | $189M | · | · | · | · | · | · | · | |
| Stock Repurchased | $88M | $522.0K | $28M | $642.0K | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $-88M | $-522.0K | $-28M | $-642.0K | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-93M | $-6M | $-30M | $-5M | $186M | $163M | $-132.0K | $50M | $29M | $25M | · | · | |
| Net Change in Cash | $-49M | $32M | $-8M | $-258M | $214M | $96M | $-26M | $38M | $9M | $-13M | $-7M | $31M | |
| Taxes Paid | $284.0K | $317.0K | $738.0K | $392.0K | $14.0K | $80.0K | $0 | $0 | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | · | $-6M | $-14M | · | · | $-4M |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | 64.2% | · | · | · | · | · | |
| Operating Margin | -8.1% | 12.2% | -72.5% | -24.0% | -10.0% | -11.7% | -19.3% | -20.3% | -42.0% | · | · | 4.6% | |
| Net Margin | -5.6% | 15.7% | -67.9% | -23.8% | -10.3% | -9.7% | -17.3% | -61.1% | -114.8% | · | · | 2.9% | |
| Pretax Margin | -5.5% | 15.8% | -67.8% | -23.7% | -10.8% | -10.3% | -18.9% | -63.0% | -118.5% | · | · | -2.6% | |
| EBITDA Margin | -4.2% | 16.5% | -67.4% | -24.0% | -10.0% | -11.7% | -19.3% | -20.3% | -42.0% | · | · | 6.5% | |
| ROA | -4.7% | 11.0% | -37.7% | -13.8% | -6.6% | -7.2% | -15.6% | -43.6% | -69.9% | · | · | 2.2% | |
| ROE | -6.8% | 16.1% | -58.1% | -17.1% | -6.5% | -6.9% | -22.4% | -104.1% | -831.1% | · | · | -1.4% | |
| ROIC | -10.3% | 10.7% | -77.9% | -18.0% | -6.1% | -7.7% | -22.7% | -15.8% | -70.5% | · | · | -2.6% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 3.9 | 4.0 | 5.1 | 5.6 | 3.9 | 2.1 | 4.2 | 0.6 | · | · | 3.6 | |
| Quick Ratio | 2.4 | 3.6 | 3.7 | 4.7 | 5.3 | 3.7 | 1.8 | 3.8 | 0.5 | · | · | 3.3 | |
| Debt / Equity | · | · | · | · | · | 0.0 | 0.0 | 0.0 | -5.6 | · | · | 0.3 | |
| LT Debt / Equity | · | · | · | · | · | 0.0 | 0.0 | 0.0 | -3.0 | · | · | 0.1 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.6 | 0.6 | 0.6 | 0.7 | 0.9 | 0.7 | 0.6 | · | · | 0.8 | |
| Inventory Turnover | · | · | · | · | · | · | 8.3 | · | 1.6 | · | · | 14.2 | |
| Receivables Turnover | 7.1 | 5.8 | 4.8 | 5.1 | 6.3 | 6.6 | 7.5 | 12.0 | 16.8 | · | · | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.95 | $6.91 | $5.07 | $8.05 | $8.80 | $5.62 | $2.33 | $2.32 | $-0.21 | · | · | $3.50 | |
| Revenue / Share | $7.13 | $5.90 | $5.21 | $6.03 | $5.67 | $4.13 | $3.01 | $2.15 | $2.07 | · | · | $2.94 | |
| Cash Flow / Share | $0.79 | $0.67 | $-0.34 | $-0.47 | $-0.37 | $0.72 | $-0.07 | $-0.11 | $-0.61 | · | · | $-0.36 | |
| Cash / Share | $1.28 | $2.09 | $1.60 | $1.68 | $6.58 | $2.72 | $0.90 | $1.56 | $0.59 | · | · | $3.09 | |
| EPS (TTM) | $-0.40 | $0.93 | $-3.54 | $-1.44 | $-0.59 | $-0.40 | $-0.52 | $-1.31 | $-2.38 | $-2.39 | $-1.16 | $0.10 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.8% | 19.1% | -12.9% | 8.6% | 54.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.7% | 4.0% | 13.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 14.6% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $380M | $334M | $280M | $322M | $296M | $192M | $127M | $77M | $48M | $41M | $28M | $27M | |
| Net Income TTM | $-21M | $53M | $-190M | $-77M | $-31M | $-19M | $-22M | $-47M | $-55M | $-39M | $-14M | $781.0K | |
| Market Cap | $959M | $1.17B | $618M | $611M | $2.41B | $3.58B | $917M | $1.04B | $212M | · | · | $86M | |
| Enterprise Value | · | · | · | · | · | $3.36B | $878M | $976M | $229M | · | · | $61M | |
| P/E | -47.1 | 23.0 | -3.4 | -7.9 | -77.1 | -181.1 | -41.5 | -19.2 | -3.1 | -1.1 | -5.5 | 72.5 | |
| P/S | 2.5 | 3.5 | 2.2 | 1.9 | 8.1 | 18.6 | 7.2 | 13.6 | 4.4 | · | · | 3.1 | |
| P/B | 3.2 | 3.1 | 2.4 | 1.4 | 5.2 | 12.9 | 9.3 | 10.8 | -34.5 | · | · | 2.1 | |
| P / Tangible Book | 4.2 | 3.9 | 3.5 | 1.7 | 6.4 | 17.1 | · | · | · | · | · | · | |
| P / Cash Flow | 22.8 | 30.8 | -33.6 | -24.2 | -124.8 | 107.1 | -331.1 | -259.7 | -14.8 | · | · | -25.5 | |
| P / FCF | · | · | · | · | · | · | · | -172.2 | -14.6 | · | · | -21.0 | |
| EV / EBITDA | · | · | · | · | · | -149.0 | -35.8 | -62.6 | -11.3 | · | · | 34.4 | |
| EV / FCF | · | · | · | · | · | · | · | -161.5 | -15.8 | · | · | -14.8 | |
| EV / Revenue | · | · | · | · | · | 17.5 | 6.9 | 12.7 | 4.7 | · | · | 2.2 | |
| Earnings Yield | -2.1% | 4.3% | -29.5% | -12.6% | -1.3% | -0.55% | -2.4% | -5.2% | -32.4% | -88.5% | -18.1% | 1.4% |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $132M | $118M | $108M | $100M | $87M | $85M | $87M | $83M | $92M | $72M | $66M | $67M | $70M | $77M | $82M | $79M | |
| R&D Expense | $22M | $21M | $19M | $17M | $17M | $19M | $17M | $17M | $20M | $19M | $19M | $19M | $20M | $24M | $24M | $22M | |
| SG&A Expense | $41M | $30M | $29M | $28M | $28M | $23M | $32M | $32M | $31M | $30M | $28M | $34M | $29M | $28M | $25M | $24M | |
| Operating Expenses | $19M | $117M | $114M | $100M | $98M | $98M | $2M | $97M | $100M | $95M | $188M | $96M | $98M | $102M | $102M | $97M | |
| Operating Income | $113M | $1M | $-6M | $-246.0K | $-11M | $-13M | $84M | $-14M | $-7M | $-23M | $-123M | $-29M | $-28M | $-24M | $-19M | $-17M | |
| Other Non-op | $-440.0K | $-330.0K | $264.0K | $-107.0K | $72.0K | $295.0K | $436.0K | $283.0K | $-100.0K | $-290.0K | $2M | $2M | $-271.0K | $-2M | $-924.0K | $-572.0K | |
| Pretax Income | $115M | $3M | $-4M | $2M | $-9M | $-10M | $88M | $-10M | $-5M | $-20M | $-118M | $-24M | $-25M | $-24M | $-18M | $-17M | |
| Income Tax | $4M | $-32.0K | $345.0K | $-15.0K | $-117.0K | $58.0K | $171.0K | $200.0K | $22.0K | $-83.0K | $165.0K | $-80.0K | $-68.0K | $124.0K | $173.0K | $267.0K | |
| Net Income | $111M | $3M | $-4M | $2M | $-9M | $-10M | $88M | $-11M | $-5M | $-20M | $-118M | $-23M | $-25M | $-24M | $-18M | $-17M | |
| EPS (Basic) | $2.15 | $0.05 | $-0.08 | $0.03 | $-0.16 | $-0.19 | $1.67 | $-0.20 | $-0.09 | $-0.38 | $-2.21 | $-0.43 | $-0.46 | $-0.44 | $-0.34 | $-0.32 | |
| EPS (Diluted) | $2.07 | $0.05 | $-0.08 | $0.03 | $-0.16 | $-0.19 | $1.60 | $-0.20 | $-0.09 | $-0.38 | $-2.21 | $-0.43 | $-0.46 | $-0.44 | $-0.34 | $-0.32 | |
| Shares (Basic) | 51,469,375 | 51,151,794 | · | 52,507,582 | 54,304,754 | 55,262,459 | · | 52,903,338 | 52,195,620 | 51,692,358 | · | 54,178,759 | 53,846,260 | 53,643,216 | · | 53,489,418 | |
| Shares (Diluted) | 53,422,523 | 53,129,928 | · | 53,736,790 | 54,304,754 | 55,262,459 | · | 52,903,338 | 52,195,620 | 51,692,358 | · | 54,178,759 | 53,846,260 | 53,643,216 | · | 53,489,418 | |
| EBITDA | $113M | $5M | · | $-246.0K | $-11M | $-10M | · | $-10M | $-4M | $-16M | · | $-29M | $-28M | $-21M | · | $-17M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $374M | $78M | $65M | $91M | $68M | $89M | $115M | $95M | $96M | $93M | $82M | $76M | $88M | $75M | $90M | $83M | |
| Short-term Investments | $0 | $109M | $112M | $103M | $118M | $142M | $146M | $145M | $133M | $123M | · | $192M | $195M | $211M | · | $208M | |
| Receivables | $34M | $45M | $43M | $48M | $67M | $71M | $65M | $67M | $66M | $60M | · | $52M | $52M | $59M | · | $70M | |
| Inventory | $7M | $26M | $27M | $28M | $28M | $23M | $20M | $19M | $19M | $20M | · | $18M | $19M | $18M | · | $18M | |
| Prepaid Expense | $14M | $11M | $11M | $30M | $26M | $25M | $7M | $7M | $6M | $7M | · | $7M | $8M | $8M | · | $8M | |
| Current Assets | $429M | $269M | $257M | $300M | $307M | $350M | $352M | $334M | $321M | $303M | · | $345M | $361M | $371M | · | $388M | |
| PP&E (Net) | $27M | $33M | $33M | $31M | $32M | $33M | $34M | $34M | $34M | $34M | · | $35M | $36M | $36M | · | $34M | |
| Goodwill | $36M | $40M | $40M | $40M | $40M | $40M | $40M | $40M | $40M | $40M | · | $40M | $40M | $40M | $38M | $38M | |
| Intangibles | $19M | $32M | $32M | $33M | $36M | $37M | $38M | $40M | $42M | $43M | · | $46M | $44M | $46M | · | $44M | |
| Other Non-current Assets | $6M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $5M | |
| Total Assets | $533M | $411M | $413M | $432M | $444M | $490M | $491M | $477M | $467M | $452M | · | $501M | $515M | $528M | · | $545M | |
| Accounts Payable | $9M | $9M | $10M | $12M | $10M | $8M | $8M | $6M | $6M | $10M | · | $9M | $10M | $13M | · | $11M | |
| Current Liabilities | $94M | $79M | $90M | $99M | $93M | $85M | $89M | $81M | $78M | $70M | · | $73M | $74M | $72M | · | $70M | |
| Capital Leases | $13M | $18M | $20M | $21M | $23M | $24M | $22M | $24M | $25M | $27M | · | $29M | $31M | $32M | · | $35M | |
| Deferred Tax | $86.0K | $130.0K | $181.0K | $117.0K | $131.0K | $129.0K | $164.0K | $202.0K | $50.0K | $43.0K | · | $140.0K | $51.0K | · | · | $13.0K | |
| Other Non-current Liabilities | $406.0K | $407.0K | $257.0K | $634.0K | $636.0K | $644.0K | $645.0K | $97M | $97M | $98M | · | $245.0K | $247.0K | $248.0K | · | $251.0K | |
| Total Liabilities | $107M | $98M | $110M | $121M | $117M | $110M | $113M | $204M | $202M | $196M | · | $107M | $110M | $108M | · | $108M | |
| Long-term Debt | · | · | · | · | · | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Common Stock | $51.0K | $51.0K | $50.0K | $51.0K | $53.0K | $51.0K | $51.0K | $50.0K | $50.0K | $49.0K | · | $52.0K | $52.0K | $52.0K | · | $52.0K | |
| Retained Earnings | $-505M | $-733M | $-735M | $-719M | $-695M | $-637M | $-626M | $-704M | $-697M | $-695M | · | $-534M | $-510M | $-485M | · | $-441M | |
| AOCI | $0 | $-6M | $-6M | $-6M | $-6M | $-7M | $-9M | $-7M | $-8M | $-8M | · | $-9M | $-8M | $-7M | · | $-9M | |
| Stockholders' Equity | $426M | $314M | $303M | $311M | $327M | $379M | $378M | $273M | $265M | $256M | $261M | $394M | $405M | $420M | $431M | $437M | |
| Liabilities + Equity | $533M | $411M | $413M | $432M | $444M | $490M | $491M | $477M | $467M | $452M | · | $501M | $515M | $528M | · | $545M | |
| Shares Outstanding | 51,482,536 | 51,274,651 | 50,916,644 | 51,407,335 | 53,220,123 | 55,462,730 | 54,771,203 | 53,106,871 | 52,617,443 | 51,782,612 | 51,503,377 | 54,153,496 | 54,013,601 | 53,653,182 | 53,533,250 | 53,523,453 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Stock-based Comp | $11M | $10M | $8M | $8M | $9M | $9M | $17M | $23M | $20M | $17M | $10M | $13M | $13M | $14M | $12M | $11M | |
| Amort. of Intangibles | $529.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | $0 | $68.0K | · | · | $0 | $848.0K | $60.0K | $0 | $0 | |
| Other Non-cash | · | $-12M | · | · | · | $-29M | · | · | · | $-16M | · | · | · | $7M | · | · | |
| Operating Cash Flow | $31M | $4M | $21M | $37M | $10M | $-27M | $22M | $13M | $19M | $-15M | $-8M | $-10M | $-499.0K | $671.0K | $7M | $-7M | |
| CapEx | $2M | $4M | · | · | $1M | $2M | · | · | · | · | · | · | · | · | · | · | |
| Investing Cash Flow | $281M | $11M | $-35M | $12M | $23M | $1M | $-2M | $-14M | $-12M | $28M | $41M | $-1M | $15M | $-15M | $2M | $-76M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Stock Repurchased | · | · | $12M | $26M | $50M | $0 | $0 | $0 | $0 | $522.0K | $26M | $814.0K | $67.0K | $690.0K | $642.0K | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $-522.0K | · | · | · | $-690.0K | · | · | |
| Financing Cash Flow | $-15M | $-3M | $-12M | $-26M | $-54M | $-643.0K | $-903.0K | $1M | $-5M | $-1M | $-27M | $-25.0K | $-2M | $-1M | $-2M | $-1M | |
| Net Change in Cash | $296M | $12M | $-26M | $23M | $-21M | $-26M | $19M | $-378.0K | $2M | $11M | $6M | $-12M | $13M | $-15M | $7M | $-84M | |
| Free Cash Flow | · | $514.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 85.8% | 1.0% | · | -0.25% | -12.8% | -15.8% | · | -12.7% | -4.4% | -26.8% | · | -42.8% | -39.3% | -31.5% | · | -21.9% | |
| Net Margin | 83.9% | 2.4% | · | 1.7% | -9.9% | -12.2% | · | -8.9% | -1.5% | -23.1% | · | -34.9% | -35.5% | -30.7% | · | -21.3% | |
| Pretax Margin | 86.8% | 2.4% | · | 1.7% | -10.0% | -12.2% | · | -8.7% | -1.5% | -23.2% | · | -35.1% | -35.6% | -30.6% | · | -21.0% | |
| EBITDA Margin | 85.8% | 4.3% | · | -0.25% | -12.8% | -11.5% | · | -12.7% | -4.4% | -21.5% | · | -42.8% | -39.3% | -27.1% | · | -21.9% | |
| ROA | 22.6% | 0.62% | · | 0.37% | -1.9% | -2.2% | · | -1.5% | -0.28% | -3.4% | · | -4.5% | -4.7% | -4.4% | · | -3.1% | |
| ROE | 29.4% | 0.81% | · | 0.57% | -2.9% | -3.3% | · | -2.2% | -0.42% | -4.9% | · | -5.7% | -5.9% | -5.4% | · | -3.7% | |
| ROIC | 25.7% | 0.39% | · | -0.08% | -3.4% | -3.5% | · | -4.0% | -1.6% | -7.5% | · | -7.3% | -6.8% | -5.8% | · | -4.0% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 3.4 | · | 3.0 | 3.3 | 4.1 | · | 4.1 | 4.1 | 4.3 | · | 4.7 | 4.8 | 5.2 | · | 5.5 | |
| Quick Ratio | 4.4 | 2.9 | · | 2.4 | 2.7 | 3.5 | · | 3.8 | 3.8 | 3.9 | · | 4.4 | 4.5 | 4.8 | · | 5.1 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 2.6 | 2.0 | · | 1.7 | 1.3 | 1.3 | · | 1.4 | 1.6 | 1.2 | · | 1.1 | 1.2 | 1.2 | · | 1.3 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.27 | $6.11 | · | $6.05 | $6.15 | $6.84 | · | $5.15 | $5.03 | $4.95 | · | $7.28 | $7.50 | $7.83 | · | $8.16 | |
| Revenue / Share | $2.47 | $2.22 | · | $1.86 | $1.60 | $1.53 | · | $1.57 | $1.77 | $1.39 | · | $1.24 | $1.31 | $1.44 | · | $1.48 | |
| Cash Flow / Share | · | $0.08 | · | · | · | $-0.48 | · | · | · | $-0.30 | · | · | · | $0.01 | · | · | |
| Cash / Share | $7.26 | $1.52 | · | $1.78 | $1.28 | $1.60 | · | $1.80 | $1.82 | $1.80 | · | $1.40 | $1.63 | $1.39 | · | $1.55 | |
| EPS (TTM) | $2.07 | $-0.16 | · | $1.28 | $1.05 | $1.12 | · | $-2.88 | $-3.11 | $-3.48 | · | $-1.67 | $-1.56 | $-1.51 | · | $-1.41 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $458M | $413M | · | $358M | $341M | $346M | · | $313M | $297M | $275M | · | $297M | $309M | $320M | · | $319M | |
| Net Income TTM | $111M | $-8M | · | $70M | $58M | $62M | · | $-153M | $-166M | $-186M | · | $-91M | $-84M | $-81M | · | $-74M | |
| Market Cap | $1.47B | $890M | · | $747M | $1.04B | $984M | · | $1.66B | $817M | $548M | · | $379M | $459M | $490M | · | $911M | |
| P/E | 13.8 | -108.5 | · | 11.4 | 18.6 | 15.8 | · | -10.8 | -5.0 | -3.0 | · | -4.2 | -5.4 | -6.1 | · | -12.1 | |
| P/S | 3.2 | 2.2 | · | 2.1 | 3.1 | 2.8 | · | 5.3 | 2.8 | 2.0 | · | 1.3 | 1.5 | 1.5 | · | 2.9 | |
| P/B | 3.4 | 2.8 | · | 2.4 | 3.2 | 2.6 | · | 6.1 | 3.1 | 2.1 | · | 1.0 | 1.1 | 1.2 | · | 2.1 | |
| P / Tangible Book | 4.0 | 3.7 | · | 3.1 | 4.1 | 3.3 | · | 8.6 | 4.5 | 3.2 | · | 1.2 | 1.4 | 1.5 | · | 2.6 | |
| P / Cash Flow | · | 205.4 | · | · | · | -37.0 | · | · | · | -35.8 | · | · | · | 730.8 | · | · | |
| Earnings Yield | 7.3% | -0.92% | · | 8.8% | 5.4% | 6.3% | · | -9.2% | -20.0% | -32.9% | · | -23.9% | -18.4% | -16.5% | · | -8.3% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $380M | $334M | $280M | $322M | $296M |
| Marża Operacyjna % | -8.1% | 12.2% | -72.5% | -24.0% | -10.0% |
| Zysk netto | $-21M | $53M | $-190M | $-77M | $-31M |
| Rozwodniony EPS | $-0.40 | $0.93 | $-3.54 | $-1.44 | $-0.59 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 2.9 | 3.9 | 4.0 | 5.1 | 5.6 |
| Wskaźnik Szybkości | 2.4 | 3.6 | 3.7 | 4.7 | 5.3 |
Brak danych dla tego sprawozdania
Zbyt mało danych fundamentalnych, aby utworzyć to sprawozdanie.
Właściciele instytucjonalni (13F) 241 emitentów · $1.6B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
241
Wartość posiadanych akcji
$1.6B
Nowe pozycje
54
Zamknięte pozycje
13
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 54 (+25 vs poprzedni kw.) | 13 (-16 vs poprzedni kw.) | 77 (+6 vs poprzedni kw.) | 66 (+8 vs poprzedni kw.) | +368K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $137 219 211 | 4 814 709 | 8,74% | Akcje |
| STATE STREET CORP | $70 362 453 | 2 468 858 | 4,48% | Akcje |
| VANGUARD GROUP INC | $64 588 269 | 3 428 252 | 4,11% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $62 628 038 | 2 197 475 | 3,99% | Akcje |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $56 932 113 | 1 997 618 | 3,63% | Akcje |
| ARK Investment Management LLC | $55 675 622 | 1 953 531 | 3,55% | Akcje |
| Boston Partners | $55 224 627 | 1 937 601 | 3,52% | Akcje |
| BAMCO INC /NY/ | $55 213 791 | 1 937 326 | 3,52% | Akcje |
| GAGNON SECURITIES LLC | $50 465 960 | 1 770 735 | 3,21% | Akcje |
| Chevy Chase Trust Holdings, LLC | $40 966 358 | 1 437 416 | 2,61% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $37 856 083 | 1 328 037 | 2,41% | Akcje |
| Ophir Asset Management Pty Ltd | $36 047 057 | 1 264 809 | 2,30% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $35 424 332 | 1 242 959 | 2,26% | Akcje |
| BRAIDWELL LP | $34 787 157 | 1 220 602 | 2,22% | Akcje |
| Sumitomo Mitsui Trust Group, Inc. | $33 961 455 | 1 191 630 | 2,16% | Akcje |
| Blue Water Life Science Advisors, LP | $33 915 000 | 1 190 000 | 2,16% | Akcje |
| Amova Asset Management Americas, Inc. | $33 848 257 | 1 188 075 | 2,16% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $33 664 351 | 1 181 077 | 2,14% | Akcje |
| D. E. Shaw & Co., Inc. | $32 423 311 | 1 137 660 | 2,07% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $28 376 566 | 995 669 | 1,81% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $28 201 577 | 989 529 | 1,80% | Akcje |
| MORGAN STANLEY | $22 067 528 | 774 299 | 1,41% | Akcje |
| Divisadero Street Capital Management, LP | $19 976 733 | 700 938 | 1,27% | Akcje |
| GOLDMAN SACHS GROUP INC | $19 949 801 | 699 993 | 1,27% | Akcje |
| Portolan Capital Management, LLC | $19 516 943 | 684 805 | 1,24% | Akcje |
| First Eagle Investment Management, LLC | $17 057 165 | 598 497 | 1,09% | Akcje |
| ROYCE & ASSOCIATES LP | $16 415 174 | 575 971 | 1,05% | Akcje |
| BANK OF AMERICA CORP /DE/ | $16 296 528 | 571 808 | 1,04% | Akcje |
| Gagnon Advisors, LLC | $15 586 451 | 546 893 | 0,99% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $15 336 563 | 538 125 | 0,98% | Akcje |
| Palo Alto Investors LP | $15 158 295 | 531 870 | 0,97% | Akcje |
| Russell Investments Group, Ltd. | $14 636 172 | 513 550 | 0,93% | Akcje |
| NORTHERN TRUST CORP | $13 645 745 | 478 798 | 0,87% | Akcje |
| JANE STREET GROUP, LLC | $13 402 781 | 470 273 | 0,85% | Akcje |
| Meridiem Capital Partners LP | $12 867 551 | 451 493 | 0,82% | Akcje |
| Invesco Ltd. | $12 745 344 | 447 205 | 0,81% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $11 456 630 | 401 987 | 0,73% | Akcje |
| Zweig-DiMenna Associates LLC | $11 081 142 | 388 812 | 0,71% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $10 684 906 | 374 909 | 0,68% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $10 605 164 | 372 111 | 0,68% | Akcje |
| Qube Research & Technologies Ltd | $10 540 355 | 369 837 | 0,67% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $10 446 419 | 366 541 | 0,67% | Akcje |
| ArrowMark Colorado Holdings LLC | $9 648 647 | 338 549 | 0,61% | Akcje |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | $8 680 000 | 500 000 | 0,55% | Akcje |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $8 441 700 | 296 200 | 0,54% | Akcje |
| Kent Lake PR LLC | $7 997 000 | 550 000 | 0,51% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $7 643 900 | 268 207 | 0,49% | Akcje |
| FMR LLC | $7 219 454 | 253 314 | 0,46% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $6 964 688 | 244 375 | 0,44% | Akcje |
| Aberdeen Group plc | $6 407 627 | 224 829 | 0,41% | Akcje |
Aktywiści i właściciele 5%+ 2 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Merckle International GmbH ×3 zgłoszenia | 28 marca 2018 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| Paragon Associates and Paragon Associates II Joint Venture, Paragon JV Partners, LLC, Bradbury Dyer III ×4 zgłoszenia | 24 stycznia 2018 | · | Pierwotne zgłoszenie | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 37 insiderów · 21 dyrektorzy generalni · 12 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| John Walter Hanna JR | President and CEO | 16 lipca 2026 M | 653 448 | 0 | 11 | $-7 540 215 |
| Reginald Seeto | President and Chief Executive Officer | 2 października 2023 S | 479 164 | 0 | 0 | $0 |
| Keith Kennedy | CFO & COO | 12 września 2026 F | 211 704 | 0 | 0 | $0 |
| Nathan Smith | Chief Financial Officer | 2 lutego 2026 F | 79 016 | 0 | 0 | $0 |
| Abhishek Jain | Chief Financial Officer | 1 sierpnia 2025 F | 319 725 | 0 | 0 | $0 |
| Ankur Dhingra | Chief Financial Officer | 25 marca 2022 F | 33 146 | 0 | 0 | $0 |
| Michael Brian Bell | Chief Financial Officer | 3 listopada 2020 M | 103 343 | 0 | 0 | $0 |
| Charles Constanti | Chief Financial Officer | 17 lutego 2017 A | 10 000 | 0 | 0 | $0 |
| Ken Ludlum | Chief Financial Officer | 22 stycznia 2016 A | 48 000 | 0 | 0 | $0 |
| Alexander L Johnson | President of Patient and Testing Services | 21 sierpnia 2024 M | 284 983 | 0 | 0 | $0 |
| Mitchell J Nelles | Chief Operating Officer | 2 lipca 2018 S | 85 160 | 0 | 0 | $0 |
| Jessica Meng | Chief Commercial Officer | 12 września 2026 F | 161 599 | 0 | 0 | $0 |
| Jeffrey Adam Novack | Secretary and General Counsel | 5 sierpnia 2026 S | 106 075 | 0 | 7 | $-452 796 |
| Abraham Ronai | Dyrektor generalny | 20 września 2023 A | 515 986 | 0 | 0 | $0 |
| Sasha King | Chief Marketing Officer | 9 sierpnia 2022 A | 78 420 | 0 | 0 | $0 |
| James P Yee | Chief Medical Officer | 1 lipca 2019 M | 42 045 | 0 | 0 | $0 |
| John Joseph Sninsky | Chief Scientific Officer | 29 stycznia 2018 F | 22 309 | 0 | 0 | $0 |
| Anders Karlsson | Chief Commercial Officer | 19 stycznia 2018 A | 9 638 | 0 | 0 | $0 |
| Todd Whitson | Chief Commercial Officer | 17 lutego 2017 A | 20 000 | 0 | 0 | $0 |
| Joshua Defonzo | Chief Commercial Officer | 22 stycznia 2016 A | 11 000 | 0 | 0 | $0 |
| Matthew J. Meyer | Chief Business Officer | 22 stycznia 2016 A | 23 025 | 0 | 0 | $0 |
| Hannah Valantine | Dyrektor | 16 lipca 2026 M | 36 686 | 0 | 3 | $-1 319 814 |
| Suresh Gunasekaran | Dyrektor | 12 czerwca 2026 A | 37 248 | 0 | 0 | $0 |
| Richard Bryan Riggsbee | Dyrektor | 12 czerwca 2026 A | 39 312 | 0 | 0 | $0 |
| Fred Cohen | Dyrektor | 12 czerwca 2026 A | 165 060 | 0 | 0 | $0 |
| Peter Maag | Dyrektor | 7 lipca 2025 S | 308 846 | 0 | 0 | $0 |
| William A Hagstrom | Dyrektor | 11 czerwca 2025 M | 53 979 | 0 | 0 | $0 |
| Grace Colon | Dyrektor | 16 czerwca 2023 A | 23 708 | 0 | 0 | $0 |
| Ralph Snyderman | Dyrektor | 4 października 2022 A | 58 177 | 0 | 0 | $0 |
| Amy Abernethy | Dyrektor | 22 stycznia 2019 M | 15 837 | 0 | 0 | $0 |
| Douglas S Miller | Dyrektor | 1 kwietnia 2017 A | 17 695 | 0 | 0 | $0 |
| Neil Gagnon | Posiadacz 10% | 31 października 2018 S | 867 744 | 0 | 0 | $0 |
| George Bickerstaff | · | 5 sierpnia 2026 S | 134 061 | 0 | 1 | $-925 600 |
| Michael Goldberg | · | 4 sierpnia 2026 S | 61 738 | 0 | 1 | $-2 103 582 |
| Christine Cournoyer | · | 4 sierpnia 2026 S | 42 943 | 0 | 1 | $-751 040 |
| Arthur A Torres | · | 15 maja 2026 S | 38 665 | 0 | 2 | $-214 650 |
| BYERS BROOK H | · | 1 lipca 2016 A | 21 912 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 44 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 4,30% | 1 531 579 NS | 31 lipca 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 2,68% | 42 385 NS | 31 lipca 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 2,09% | 91 120 SH | 2 października 2026 | Dziennie |
| SAWS · ETF Series Solutions | 1,43% | 2 554 NS | 31 lipca 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 1,07% | 88 521 NS | 31 lipca 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0,95% | 229 825 NS | 31 lipca 2026 | N-PORT |
| IWC · iShares Trust | 0,61% | 174 097 SH | 11 września 2026 | Dziennie |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,57% | 34 673 SH | 2 października 2026 | Dziennie |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,48% | 18 953 SH | 2 października 2026 | Dziennie |
| LABU · Direxion Shares ETF Trust | 0,34% | 38 851 NS | 31 lipca 2026 | N-PORT |
| IBB · iShares Trust | 0,17% | 356 183 SH | 11 września 2026 | Dziennie |
| IWO · iShares Trust | 0,17% | 482 280 SH | 11 września 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,16% | 63 788 SH | 2 października 2026 | Dziennie |
| NUSC · Nushares ETF Trust | 0,14% | 42 483 NS | 31 lipca 2026 | N-PORT |
| ESML · iShares Trust | 0,12% | 69 521 SH | 11 września 2026 | Dziennie |
| PKW · Invesco Exchange-Traded Fund Trust | 0,12% | 30 292 SH | 2 października 2026 | Dziennie |
| PWS · Pacer Funds Trust | 0,10% | 531 NS | 31 lipca 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,09% | 54 986 SH | 19 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,08% | 1 317 079 SH | 11 września 2026 | Dziennie |
| VFMF · VANGUARD WELLINGTON FUND | 0,08% | 19 899 SH | 19 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,07% | 24 512 NS | 31 lipca 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,05% | 172 629 NS | 31 lipca 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 295 088 SH | 19 sierpnia 2026 | Dziennie |
| ISCG · iShares Trust | 0,04% | 7 437 SH | 11 września 2026 | Dziennie |
| VFQY · VANGUARD WELLINGTON FUND | 0,03% | 4 860 SH | 19 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 20 688 NS | 31 lipca 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 2 782 SH | 11 września 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 591 907 SH | 19 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,02% | 131 033 SH | 19 sierpnia 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,01% | 136 968 NS | 31 lipca 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 4 263 NS | 31 lipca 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 3 171 NS | 31 lipca 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 710 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 4 121 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 76 915 SH | 11 września 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,00% | 10 288 NS | 31 lipca 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,00% | 12 572 NS | 31 lipca 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 13 233 SH | 8 września 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,00% | 12 950 NS | 31 lipca 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 554 868 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4 148 SH | 19 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | · | 2 150 SH | 11 września 2026 | Dziennie |
| ISCV · iShares Trust | · | 5 217 SH | 11 września 2026 | Dziennie |
| SMLF · iShares Trust | · | 60 988 SH | 11 września 2026 | Dziennie |
CDNA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 13 analityków
KUP
Średni cel
$61.00
-9,2%
5 38,5%
Mocne kupno
4 30,8%
Kup
4 30,8%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
6 analityków · 2026-10-02Średnia cel $58.83 -12,4%
Teraz
Aktualna cena $67.15
Niski$46.00
Średnia$58.83
Wysoki$74.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | · |
| LEGN | · | -26.8 | · | · | -29.1% | · |
| PBLS | · | · | · | · | · | · |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | · |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| CELC | $4.81B | -26.3 | · | · | -244.3% | · |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | · |
| DNLI | $2.58B | -5.6 | 204.7% | · | -50.2% | · |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | · |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | · |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | · |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Lip 30, 2026